Office Center at Princeton Meadows 666 Plainsboro Rd, Ste 356Plainsboro, NJ 08536

4-5 November 2016Hyatt Regency Paris Étoile Paris, France

Paris Lymphoma™

This activity is provided by Physicians’ Education Resource®, LLC.

An application has been made to the EACCME® for CME accreditation of this event.

PER® complies with all applicable laws, rules, and regulations and as such, we may be required to collect information on transfers of value provided to healthcare professionals or healthcare organization.

ACCREDITATION/DESIGNATION OF CREDIT INFORMATION

Advancing Cancer Care Through Professional Education®

Use code EI16H2* before 2 November 2016 to register now and save €75*for physicians use only Nurses use code EI16H2N before 2 November 2016 to register now and save €50

Jean-Paul Fermand, MDHead of Immuno-hematology St. Louis HospitalParis, France

Véronique LeBlond, MDHead of the Department of HematologyPitié-Salpêtrière HospitalParis, France

Prof. Steven Le Gouill, MD, PhDClinical Hematology DepartmentUniversity Hospital of NantesNantes, France

Noel Milpied, MDProfessor of HematologyChief of ServiceHematology and Cell TherapyBordeaux University HospitalBordeaux, France

EUROPEAN PLANNING COMMITTEE:

4-5 November 2016 Hyatt Regency Paris Étoile Paris, France

Use code EI16H2* before 2 November 2016 to register now and save €75*for physicians use only Nurses use code EI16H2N before 2 November 2016 to register now and save €50

Paris Lymphoma™

PROGRAM CHAIR: CO-CHAIR:

Anas Younes, MDProfessor and Chief, Lymphoma ServiceDivision of Hematologic OncologyMemorial Sloan Kettering Cancer CenterNew York, New York, USA

Gilles A. Salles, MD, PhDUniversity ProfessorDepartment HeadUniversité Claude Bernard Lyon- 1Hospices Civils de LyonLyon, France

PROGRAM CHAIR: CO-CHAIR:

Anas Younes, MDProfessor and Chief, Lymphoma ServiceDivision of Hematologic OncologyMemorial Sloan Kettering Cancer CenterNew York, New York, USA

Gilles A. Salles, MD, PhDUniversity ProfessorDepartment HeadUniversité Claude Bernard Lyon- 1Hospices Civils de LyonLyon, France

Jean-Paul Fermand, MDHead of Immuno-hematology St. Louis HospitalParis, FranceVéronique LeBlond, MDHead of the Department of HematologyPitié-Salpêtrière HospitalParis, France

Prof. Steven Le Gouill, MD, PhDClinical Hematology DepartmentUniversity Hospital of NantesNantes, FranceNoel Milpied, MDProfessor of HematologyChief of ServiceHematology and Cell TherapyBordeaux University HospitalBordeaux, France

Jennifer R. Brown, MD, PhDAssociate Professor of MedicineHarvard Medical SchoolDirector, CLL CenterDana-Farber Cancer InstituteBoston, MA

Prof. Laurence de Leval, MD PhDDirector of the Institute of PathologyUniversity Hospital of LausanneLausanne, Switzerland

Prof. Dr. Andreas Engert, MDDepartment I of Internal MedicineUniversity Hospital of CologneCologne, Germany

Andre Goy, MD, MSChairman and Director, Chief of LymphomaDirector, Clinical and Translational Cancer ResearchJohn Theurer Cancer Center at HackensackUniversity Medical CenterProfessor of Medicine, Georgetown University Hackensack, NJ

Prof. Corinne Haioun, MD, PhDProfessor of Hematology CHU Henri Mondor CréteilCedex, France

Shaji Kumar, MDProfessor of MedicineDivision of HematologyMayo ClinicRochester, MN

Prof. Phillippe Moreau, MDHead of the Hematology DepartmentUniversity Hospital of NantesCedex, France

Franck Morschhauser, MD, PhDProfessor of HematologyCentre Hospitalier Régional Universitaire de LilleLille, France

Prof. Simon Rule, MDProfessor of Clinical HaematologyPlymouth University Peninsula School of Medicine and DentistryPlymouth, United Kingdom

Steven Treon, MD, PhDDirector, Bing Center for Waldenström’s MacroglobulinemiaDana-Farber Cancer Institute Associate Professor of Medicine Harvard Medical SchoolBoston, MA

William G. Wierda, MD, PhDProfessor, Department of Leukemia, Division of Cancer MedicineHead of CLL Section, Department of LeukemiaLeukemia Center Medical Director and Executive Medical Director for Hematologic MalignanciesThe University of Texas MD Anderson Cancer CenterHouston, TX

Thomas E. Witzig, MDProfessor of Medicine, Mayo Medical SchoolCo-PI, University of Iowa/Mayo Clinic Lymphoma SPOREDeputy Director of Clinical Research, Mayo Clinic Cancer CenterRochester, MN

EUROPEAN PLANNING COMMITTEE:

FACULTY:

Friday, 4 November 20167:00 Registration and Breakfast8:00 Welcome, Introductions, and Pre-Session SurveyDiffuse Large B-Cell Lymphoma8:15 Current Standards in the Frontline Management of Diffuse Large B-Cell Lymphoma Thomas E. Witzig, MD

9:15 Strategies for Patients With Diffuse Large B-Cell Lymphoma Who Fail First-Line Therapy Prof. Corinne Haioun, MD, PhD

10:15 BreakChronic Lymphocytic Leukemia10:40 State-of-the-Art in Frontline Treatment of Patients With Chronic Lymphocytic Leukemia William G. Wierda, MD, PhD

11:40 New Treatment Options in Relapsed/Refractory Chronic Lymphocytic Leukemia Jennifer R. Brown, MD, PhD

12:40 Post-session survey12:45 Lunch14:00 Pre-Session surveySpecial Lecture

14:05 Update on the WHO Classification of Lymphoid Neoplasms: What This Means for Your Practice Prof. Laurence de Leval, MD, PhD

14:40 Question-and-Answer SessionFollicular Lymphoma14:45 How I Choose First-Line Therapy for My Patients With Follicular Lymphoma Gilles Salles, MD, PhD

15:45 Break

16:10 Treatment Options for Patients With Relapsed/Refractory Follicular Lymphoma Franck Morschhauser, MD, PhD

17:10 Post-Session survey17:15 Adjourn

Saturday, 5 November 20167:00 Registration and Breakfast8:00 Opening Remarks and Pre-Session SurveyMantle-Cell Lymphoma8:10 Optimizing Treatment for Patients With Newly Diagnosed Mantle-Cell Lymphoma Professor Simon Rule, MD

9:10 Expanding Options for Patients With Relapsed/Refractory Mantle-Cell Lymphoma Andre Goy, MD, MS

10:10 BreakHodgkin Lymphoma10:35 First-Line Standards of Care in Hodgkin Lymphoma Prof. Dr. Andreas Engert, MD

11:35 New Developments for Patients With Relapsed Hodgkin Lymphoma Anas Younes, MD

12:35 Post-Session survey12:40 Lunch13:55 Pre-Session surveyMultiple Myeloma14:00 Treatment of Younger Patients With Multiple Myeloma Prof. Philippe Moreau, MD

15:00 Break15:25 Managing Elderly Patients With Multiple Myeloma Shaji Kumar, MD

Waldenström’s Macroglobulinemia16:25 Waldenström's Macroglobulinemia: Current Approaches and a Look to 2017 Steven Treon, MD, PhD

17:25 Post-Session survey17:30 Closing Remarks and Adjourn

*Agenda Accurate at Time of Printing

AGENDA Each lecture is followed by a 45-minute Case-Based Panel Discussion